Increased demand for asthma, chronic obstructive pulmonary disease (COPD), and cough and cold subgroups driven the demand for respiratory drugs and also a surge in OPD admissions too, according to medical experts and industry insiders. Sales of...
Conduit Pharmaceutical's collaboration with Sarborg strengthens their dedication to using AI-based solutions to promote growth, provide value to shareholders, and sustain a competitive advantage in the pharmaceutical industry. Conduit is dedicated...
The global heparin market is fueled by the rising incidence of coagulation disorders, alongside a growing focus on Research and Development efforts and novel therapeutic uses of heparin. The market is projected to expand by USD 3.34 billion from...
As we approach the 8th Annual Pharma Project and Portfolio Management 2025, the anticipation is palpable. Over the last seven editions, this event has grown into a must-attend for industry leaders, becoming synonymous with high-level discussions.
The 3rd Edition Drug Safety Symposium 2025 – Dubai Chapter, taking place on February 12th –13th, 2025, is set to be an extraordinary event that not only builds on the successes of its previous editions but also introduces something even more exciting
Indian pharmaceutical firms, having gained from favorable sector trends like steady generic pricing and opportunities arising from shortages, alongside stable raw material costs over the last 18-24 months, are expected to advance further in...
Afrezza is the first and sole noninjection insulin created for individuals with both type 1 and type 2 diabetes mellitus. Afrezza, created and produced by MannKind Corporation (MannKind) in the USA, is intended to enhance glycemic control in adult...
The expansion of the global counterfeit drug detection device market is propelled by a compounded annual growth rate (CAGR) of 3.3% in the upcoming ten years, indicating an increased international emphasis on addressing the rising issue of fake...
The market for pharmaceutical manufacturing equipment is expanding quickly due to the increasing demand for pharmaceuticals, particularly generic medications. Generic medications provide a cost-effective substitute for brand-name drugs and have...
The Foreign Direct Investment (FDI) equity into the pharmaceutical industry has shown significant growth in the first half of 2024-25, following a 48 percent drop in fiscal 2023-24 compared to the prior year. The quarter from April to September of...
, CDSCO.jpg)
